Corvus Pharmaceuticals, Inc. - COM (CRVS)

Historical Portfolio Holders from Q1 2016 to Q1 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	17.6 M	$31.4 M	-$2.32 M	53.8 K	53.2 K	$1.78	44
2023 Q4	18.9 M	$33.3 M	-$27.3 K	137 K	37.8 K	$1.76	45
2023 Q3	19.2 M	$28 M	-$1.23 M	103 K	70.2 K	$1.46	52
2023 Q2	19.5 M	$44.6 M	+$735 K	255 K	133 K	$2.29	52
2023 Q1	20.7 M	$18.9 M	-$164 K	0	10 K	$0.91	34
2022 Q4	21.3 M	$18.1 M	-$597 K	935	9.44 K	$0.85	35
2022 Q3	22 M	$18 M	-$3.3 M	0	10 K	$0.82	36
2022 Q2	25.5 M	$25.3 M	-$3.29 M	35 K	36 K	$0.99	38
2022 Q1	27.4 M	$44.9 M	-$1.21 M	106 K	153 K	$1.64	48
2021 Q4	27.7 M	$66.7 M	-$7.83 M	325 K	303 K	$2.41	58
2021 Q3	28.1 M	$136 M	+$22.8 M	2.46 M	5.7 M	$4.84	57
2021 Q2	23.7 M	$63.2 M	+$8.57 M	245 K	79 K	$2.67	43
2021 Q1	20.4 M	$62.8 M	+$12.1 M	435 K	78 K	$3.08	46
2020 Q4	16.3 M	$58.1 M	-$3.25 M	129 K	224 K	$3.56	33
2020 Q3	16.6 M	$66.6 M	-$11.8 M		195 K	$4.01	31
2020 Q2	20.4 M	$55.6 M	-$392 K			$2.72	32
2020 Q1	20.7 M	$43.6 M	-$3.31 M			$2.11	34
2019 Q4	20.8 M	$113 M	-$10.4 M			$5.44	34
2019 Q3	22.9 M	$68.9 M	-$4.06 M			$3.01	33
2019 Q2	24.3 M	$90.9 M	-$1.48 M			$3.74	42
2019 Q1	24 M	$96.4 M	-$918 K			$4.02	53
2018 Q4	25.1 M	$92.2 M	-$2.05 M			$3.67	58
2018 Q3	24.9 M	$213 M	-$3.36 M			$8.58	55
2018 Q2	25.4 M	$279 M	+$903 K			$10.98	53
2018 Q1	25.3 M	$288 M	+$90.6 M			$11.53	53
2017 Q4	16.7 M	$174 M	-$6.13 M			$10.36	52
2017 Q3	17.5 M	$280 M	+$1.09 M			$15.94	51
2017 Q2	17.5 M	$212 M	-$2.85 M			$12.10	47
2017 Q1	17.3 M	$360 M	+$9.74 M			$20.77	52
2016 Q4	17.5 M	$250 M	+$17.4 M			$14.30	53
2016 Q3	16.3 M	$268 M	-$17 M			$16.45	44
2016 Q2	14.6 M	$208 M	+$14.5 M			$14.26	43
2016 Q1	13.6 M	$197 M	+$197 M			$14.50	30